Hyperemesis Gravidarum

That this House recognises the significant impact of Hyperemesis Gravidarum (HG), which affects around 3% of pregnancies in the UK; notes with concern the lack of diagnostic training given to general practitioners who first see sufferers before the first appointment with a midwife, which tends to come in the ninth week of pregnancy; acknowledges the personal toll on the physical and mental health of women who do not receive a formal diagnosis of HG and are left feeling isolated and unsupported when symptoms are misdiagnosed as morning sickness; calls for the end to the postcode lottery of access to drugs to treat symptoms of nausea and vomiting, including Xonvea; and urges the Government to work with Pregnancy Sickness Support and relevant stakeholders to update clinical guidelines and improve training to support early diagnosis and safer treatment options.